-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At the beginning of the "14th Five-Year Plan", Yantai City, Shandong attaches great importance to the development of the biopharmaceutical industry, makes every effort to strengthen the biopharmaceutical industry chain, and build a vertical industrial ecosystem
.
It is understood that the current main business income of Yantai's biomedical industry has exceeded 100 billion yuan, forming a whole industry chain system covering the R&D, manufacturing and circulation of biological drugs, chemical drugs, modern Chinese medicines, and medical devices
.
Yantai plans to exceed 200 billion yuan in revenue from the main business of the biopharmaceutical industry by 2023
.
Yantai Development Zone is located at the eastern end of the Shandong Peninsula and has significant geographical advantages
.
Sea, land, and air transportation extend in all directions, gathering major facilities such as Yantai West Port Area, Yantai International Airport, Free Trade Port Area, and Dajijia Railway Station.
The expressways in the area are two vertical and two horizontal, and the Delongyan Railway And the planned and constructed Bohai-Rim high-speed rail passes through the border, building a multi-directional, three-dimensional transportation network
.
It is understood that in order to better promote the development of the biopharmaceutical industry, Yantai has formulated "Several Opinions on Promoting the High-Quality Development of the Biopharmaceutical Industry in the City", which clarifies the industry development direction in the next three years, that is, Yantai City will implement chain-master pilot projects and innovation Platform engineering, clinical collaboration engineering, carrier construction engineering, talent introduction and education engineering, financial assistance engineering, digital integration engineering, recruitment and expansion engineering, and technological breakthrough engineering are nine major projects, which comprehensively promote the development of the industry
.
In addition, Yantai City has also issued the "Several Policies for Promoting the High-Quality Development of the Biomedical Industry in Yantai", which vigorously supports and encourages the innovative development of the biomedical industry and promotes the implementation of major projects
.
The policy states that real money will be provided in 33 sub-fields in nine major areas, and funds as high as 50 million yuan will be given as rewards and support
.
In addition, for the industrialization project of the introduction of original new drugs for the treatment of major diseases, support of up to 100 million yuan will be given by adopting the method of "one matter, one discussion"
.
Superior transportation location and logistics conditions, preferential policy support, and complete supporting services escort the development of the biopharmaceutical industry.
It is an ideal place for investment in the biopharmaceutical industry and a new hot spot for business development
.
The strong foundation of the biomedical industry and the booming biomedical companies demonstrate that Yantai Development Zone has become a fertile ground for investment in the biomedical industry..
The data shows that in Yantai, there are 55 companies in the biomedical field with sales revenue exceeding 100 million yuan, 13 companies exceeding 1 billion yuan, and 5 companies are listed at home and abroad
.
At present, the main business income of Yantai's biomedical industry has exceeded 100 billion yuan.
According to the plan, by 2023, the main business income of the balcony biomedical industry will exceed 200 billion yuan, of which high-end pharmaceutical equipment manufacturing accounts for more than 60%
.
In addition, data shows that Yantai City has 651 drug approval numbers, focusing on the production of 46 drugs, including innovative products such as Jinyouli, Endu, Heparin Sodium, and Antai, microspheres, transdermal drug delivery, and liposomes.
Technology, oral repair membrane, hyperbaric oxygen chamber, and biological medicine CDMO technology have a relatively high level
.
It is understood that in the future, Yantai Development Zone will focus on “building innovative industrial clusters and cultivating new driving forces for development”, with talents, technology, capital, and platforms as the starting point, focusing on the promotion of biopharmaceuticals, medical devices, biological health products and cosmetics, The comprehensive utilization of marine biological resources, bio-agriculture and other high-end development and scale expansion will create a nationally influential biomedicine and health industry innovation highland
.
.
It is understood that the current main business income of Yantai's biomedical industry has exceeded 100 billion yuan, forming a whole industry chain system covering the R&D, manufacturing and circulation of biological drugs, chemical drugs, modern Chinese medicines, and medical devices
.
Yantai plans to exceed 200 billion yuan in revenue from the main business of the biopharmaceutical industry by 2023
.
Yantai Development Zone is located at the eastern end of the Shandong Peninsula and has significant geographical advantages
.
Sea, land, and air transportation extend in all directions, gathering major facilities such as Yantai West Port Area, Yantai International Airport, Free Trade Port Area, and Dajijia Railway Station.
The expressways in the area are two vertical and two horizontal, and the Delongyan Railway And the planned and constructed Bohai-Rim high-speed rail passes through the border, building a multi-directional, three-dimensional transportation network
.
It is understood that in order to better promote the development of the biopharmaceutical industry, Yantai has formulated "Several Opinions on Promoting the High-Quality Development of the Biopharmaceutical Industry in the City", which clarifies the industry development direction in the next three years, that is, Yantai City will implement chain-master pilot projects and innovation Platform engineering, clinical collaboration engineering, carrier construction engineering, talent introduction and education engineering, financial assistance engineering, digital integration engineering, recruitment and expansion engineering, and technological breakthrough engineering are nine major projects, which comprehensively promote the development of the industry
.
In addition, Yantai City has also issued the "Several Policies for Promoting the High-Quality Development of the Biomedical Industry in Yantai", which vigorously supports and encourages the innovative development of the biomedical industry and promotes the implementation of major projects
.
The policy states that real money will be provided in 33 sub-fields in nine major areas, and funds as high as 50 million yuan will be given as rewards and support
.
In addition, for the industrialization project of the introduction of original new drugs for the treatment of major diseases, support of up to 100 million yuan will be given by adopting the method of "one matter, one discussion"
.
Superior transportation location and logistics conditions, preferential policy support, and complete supporting services escort the development of the biopharmaceutical industry.
It is an ideal place for investment in the biopharmaceutical industry and a new hot spot for business development
.
The strong foundation of the biomedical industry and the booming biomedical companies demonstrate that Yantai Development Zone has become a fertile ground for investment in the biomedical industry..
The data shows that in Yantai, there are 55 companies in the biomedical field with sales revenue exceeding 100 million yuan, 13 companies exceeding 1 billion yuan, and 5 companies are listed at home and abroad
.
At present, the main business income of Yantai's biomedical industry has exceeded 100 billion yuan.
According to the plan, by 2023, the main business income of the balcony biomedical industry will exceed 200 billion yuan, of which high-end pharmaceutical equipment manufacturing accounts for more than 60%
.
In addition, data shows that Yantai City has 651 drug approval numbers, focusing on the production of 46 drugs, including innovative products such as Jinyouli, Endu, Heparin Sodium, and Antai, microspheres, transdermal drug delivery, and liposomes.
Technology, oral repair membrane, hyperbaric oxygen chamber, and biological medicine CDMO technology have a relatively high level
.
It is understood that in the future, Yantai Development Zone will focus on “building innovative industrial clusters and cultivating new driving forces for development”, with talents, technology, capital, and platforms as the starting point, focusing on the promotion of biopharmaceuticals, medical devices, biological health products and cosmetics, The comprehensive utilization of marine biological resources, bio-agriculture and other high-end development and scale expansion will create a nationally influential biomedicine and health industry innovation highland
.
